Blood factors as biomarkers in osteoporosis: points from the COVID-19 era
{{output}}
The restrictions adopted during the coronavirus disease 2019 (COVID-19) pandemic limiting direct medical consultations and access to healthcare centers reduced the participation of patients with chronic diseases, such as osteoporosis (OP), in screening and mon... ...
